Table 1.
Demographics and clinical characteristics of patients in the CIK treatment and surgery alone groups.
Clinicopathological variables | Surgery alone group (n = 217) | CIK treatment group (n = 231) | p value |
---|---|---|---|
Age (y) | 0.292 | ||
<50 | 118 | 137 | |
≥50 | 99 | 94 | |
Median (range) | 48 (22–74) | 47 (14–80) | |
Gender | 0.068 | ||
Male | 198 | 198 | |
Female | 19 | 33 | |
Capsule | 0.880 | ||
Complete | 183 | 196 | |
Incomplete | 34 | 35 | |
Tumor size (cm) | 0.781 | ||
≤5 | 93 | 96 | |
>5 | 124 | 135 | |
TNM stage | 0.539 | ||
I | 122 | 136 | |
II | 31 | 25 | |
III | 64 | 70 | |
Tumor number | 0.142 | ||
Single | 181 | 180 | |
Multiple | 36 | 51 | |
Histological differentiation | 0.653 | ||
Well | 34 | 43 | |
Moderate | 133 | 133 | |
Poor | 50 | 55 | |
Virus infection | 0.090 | ||
HBV | 195 | 198 | |
HCV | 1 | 1 | |
HBV+HCV | 3 | 1 | |
Non | 18 | 31 | |
Child-Pugh classes | 0.414 | ||
A | 205 | 222 | |
B | 12 | 9 | |
Alcoholic liver disease | 0.924 | ||
Yes | 9 | 10 | |
No | 208 | 221 | |
NASH | 0.700 | ||
Yes | 8 | 7 | |
No | 209 | 224 | |
AFP (ng/mL) | 0.433 | ||
Median | 173.3 | 254.5 | |
Range | 0.64–1,21,000 | 0-1,21,000 | |
PD-L1 | 0.960 | ||
<1% | 111 | 116 | |
1–5% | 54 | 57 | |
≥5% | 52 | 58 |
HBsAg, Hepatitis B surface antigen; AFP, α-fetoprotein; NASH, non-alcoholic steatohepatitis.